Saturday, December 14, 2019

 


Canopy Growth Corp
(TSX: WEED.TO) Add to Watchlist
$27.28
-0.57 (-2.05%)
as of Dec 13, 2019

Last 27.28
Change -0.57 (-2.05%)
Open 28.33
Prev. Close 27.85
Today's Range
27.22 29.33
52wk Range
18.23 70.98
Volume 4,529,653
Avg Volume 3,470,667

Recent Headlines
Canopy Growth's first line of CBD products are available for purchase through e-commerce platform available at www.firstandfree.com  (full story)
WEED.TO: 27.28 (-0.57), CGC: 20.68 (-0.45)
It seems that every new report on projected revenues in the cannabis markets, global and U.S and North America, all seem to agree on one thing: The cannabidiol (CBD) revolution will continue to rise. An industry insider, Technavio, who has been monitoring the global cannabis-infused edible products  (full story)
TGOD.TO: 0.83 (+0.01), SING: 0.0101 (+0.0001), MJNA: 0.0246 (-0.0004), MCIG: 0.0230 (-0.0011), CGC: 20.68 (-0.45), WEED.TO: 27.28 (-0.57), TGODF: 0.6250 (+0.0070)
TORONTO — Some of the most active companies traded Monday on the Toronto Stock Exchange:  (full story)
ACB.TO: 3.47 (+0.03), ECA.TO: 5.56 (+0.04), WEED.TO: 27.28 (-0.57), WM.TO: 0.83 (+0.02), ENB.TO: 50.57 (+0.17), MFC.TO: 25.40 (-0.25), TCL-A.TO: 14.90 (+1.19)
Mark Zekulin to Step Down Within Current Year as Planned  (full story)
WEED.TO: 27.28 (-0.57), CGC: 20.68 (-0.45)
SMITH FALLS, Ont. — Canopy Growth Corp. has named a veteran Constellation Brands executive as its new chief executive.  (full story)
WEED.TO: 27.28 (-0.57)
Performance Comparison
Name Today 3-Month 1-Year
WEED.TO -2.05% -12.40% -33.63%
$TXCX +0.33% +3.87% +15.27%
$TXCI +0.25% +3.82% +14.56%
DJIA +0.01% +7.38% +14.38%
S&P 500 +0.01% +8.87% +19.55%

Key Statistics
Annual EPS -5.38
Dividend & Yield -- (--)
P/E Ratio N/A
Market Capitalization, $K 9,700,930
Weighted Alpha -42.20
Standard Deviation -0.31
Profit Margin -5.59%
Beta 4.47

Growth Rates
YTD -25.48%
1-Year -34.22%
3-Year +171.71%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.